Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin familyEVENS, Andrew M; SCHUMACKER, Paul T; HOLMGREN, Arne et al.British journal of haematology. 2008, Vol 141, Num 5, pp 676-680, issn 0007-1048, 5 p.Article

Early Posttransplant Lymphoproliferative Disease: Clinicopathologic Features and Correlation With mTOR Signaling Pathway ActivationNELSON, Beverly P; WOLNIAK, Kristy L; EVENS, Andrew et al.American journal of clinical pathology. 2012, Vol 138, Num 4, pp 568-578, issn 0002-9173, 11 p.Article

CD23+ Mantle Cell Lymphoma : A Clinical Pathologic Entity Associated With Superior Outcome Compared With CD23-DiseaseKELEMEN, Katalin; PETERSON, Loann C; GORDON, Leo I et al.American journal of clinical pathology. 2008, Vol 130, Num 2, pp 166-177, issn 0002-9173, 12 p.Article

Hypoxia-Inducible Factor-1 α Expression Predicts Superior Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOPEVENS, Andrew M; SEHN, Laurie H; GASCOYNE, Randy D et al.Journal of clinical oncology. 2010, Vol 28, Num 6, pp 1017-1024, issn 0732-183X, 8 p.Article

Instability of Immunophenotype in Plasma Cell MyelomaWENQING CAO; GOOLSBY, Charles L; NELSON, Beverly P et al.American journal of clinical pathology. 2008, Vol 129, Num 6, pp 926-933, issn 0002-9173, 8 p.Article